- The report contains detailed information about Covance Inc. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
- Another part of the report is a SWOT-analysis carried out for Covance Inc.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
- The Covance Inc. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
- In the part that describes Covance Inc. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
- Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Covance Inc. business.
About Covance Inc.
Covance Inc., a drug development services company, provides early-stage and late-stage product development services to the pharmaceutical, biotechnology and medical device industries. The company also provides laboratory testing services to the chemical, agrochemical and food industries.
The company provides services in two segments, including Early Development Services, which includes preclinical services and clinical pharmacology services, and Late-Stage Development Services, which includes central laboratory, clinical development, and commercialization services (periapproval and market access services).
The companys preclinical services include toxicology services, pharmaceutical chemistry and related services. Its preclinical area introduces new technologies for client access to data, such as StudyTracker, electronic animal identification, multimedia study reports and animal and test tube measures of induced cell proliferation or reproduction.
StudyTracker is an Internet-based client access product which allows customers of toxicology, bioanalytical, metabolism and reproductive and developmental toxicology services to review study data and schedules on a near real-time basis. It has laboratories in Madison, Wisconsin; Greenfield, Indiana and Vienna, Virginia in the United States and Harrogate, United Kingdom and Muenster, Germany in Europe. It also has bioanalytical laboratories in the United States in Indianapolis, Indiana and Chantilly, Virginia, and an administrative and a sales office in Tokyo, Japan.
Toxicology: The companys preclinical toxicology services include in vivo toxicology studies, which are studies of the effects of drugs in animals, genetic toxicology studies, which include studies of the effects of drugs on chromosomes, as well as on genetically modified mice, and other specialized toxicology services. It provides immunotoxicology services in which it assesses the impact of drugs or chemicals on the structure and function of the immune system and reproductive toxicology services which help its clients access the risk that a new medicine may cause birth defects.
Pharmaceutical Chemistry: In its pharmaceutical chemistry services, the company determines the metabolic profile and bioavailability of drug candidates. The company also provides laboratory testing services to the chemical and agricultural chemical industries. It offers a range of services to agricultural chemical manufacturers to determine the potential risk to humans, animals and the environment from plant protection products, such as pesticides.
Nutritional Chemistry: In its nutritional chemistry services, the company offers a range of services to the food, nutriceutical, and animal feed industries, including nutritional analysis, nutritional content fact labels, safety analysis, and stability testing.
Research Products: The company provides custom polyclonal and monoclonal antibody services for research purposes and purpose-bred animals for biomedical research. It also offers monoclonal antibodies with the purchase of Signet of Dedham, Massachusetts. Signet provides monoclonal antibodies used in the research of cancer, and infectious and other diseases. The purpose-bred research animals the company provides are required by pharmaceutical and biotechnology companies, university research centers and contract research organizations as part of required preclinical animal safety and efficacy testing. Through various processes, technology and specifically constructed facilities, the company provides purpose-bred, pre-acclimated and specific pathogen free animals that meet its clients' rigorous quality control requirements.
Discovery Services: The company provides lead optimization services, including custom immunology and antibody services, metabolism studies and pharmacokinetic screening as well as non-GLP toxicology, in vivo pharmacology, imaging services and biomarker services.
Bioanalytical Services: The companys bioanalytical testing service, which is conducted in its bioanalytical laboratory in Indianapolis, Indiana and in its immunoanalytical facility i
The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.
1. COVANCE INC. COMPANY PROFILE
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History
2. COVANCE INC. BUSINESS OVERVIEW
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units
3. COVANCE INC. SWOT ANALYSIS
4. COVANCE INC. FINANCIAL ANALYSIS
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot
5. COVANCE INC. COMPETITORS AND INDUSTRY ANALYSIS
5.1. Covance Inc. Direct Competitors
5.2. Comparison of Covance Inc. and Direct Competitors Financial Ratios
5.3. Comparison of Covance Inc. and Direct Competitors Stock Charts
5.4. Covance Inc. Industry Analysis
5.4.1. Pharmaceuticals and Biotechnology Industry Snapshot
5.4.2. Covance Inc. Industry Position Analysis
6. COVANCE INC. NEWS & EVENTS
6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events
7. COVANCE INC. EXPERTS REVIEW1
7.1. Experts Opinion
7.2. Experts Estimates
8. COVANCE INC. ENHANCED SWOT ANALYSIS2
9. UNITED STATES PESTEL ANALYSIS2
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors
10. COVANCE INC. IFE, EFE, IE MATRICES2
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix
11. COVANCE INC. PORTER FIVE FORCES ANALYSIS2
12. COVANCE INC. VRIO ANALYSIS2
APPENDIX: RATIO DEFINITIONS
LIST OF TABLES
Covance Inc. Key Facts
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Covance Inc. Key Executives
Key Executives Biographies1
Key Executives Compensations1
Covance Inc. Major Shareholders
Covance Inc. History
Covance Inc. Products
Revenues by Segment
Revenues by Region
Covance Inc. Offices and Representations
Covance Inc. SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Covance Inc. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Covance Inc. Capital Market Snapshot
Covance Inc. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Pharmaceuticals and Biotechnology Industry Statistics
Covance Inc. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Covance Inc. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Revenue Estimates Trend1
Earnings Estimates Trend1
LIST OF FIGURES
Covance Inc. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Covance Inc. 1-year Stock Charts
Covance Inc. 5-year Stock Charts
Covance Inc. vs. Main Indexes 1-year Stock Chart
Covance Inc. vs. Direct Competitors 1-year Stock Charts
Covance Inc. Article Density Chart
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.
Enhanced SWOT Analysis
- How to use the strengths to take advantage of the opportunities?
- How to use the strengths to reduce likelihood and impact of the threats?
- How to overcome the weaknesses that obstruct taking advantage of the opportunities?
- How to overcome the weaknesses that can make the threats a reality?
Key Factors Examined by PESTEL Analysis:
- Legal – What laws and legislation will exert influence on the style the business is carried out?
IFE, EFE, IE Matrices
Porter Five Forces Analysis
- What composes a threat of substitute products and services?
- Is there a threat of new competitors entering the market?
- What is the intensity of competitive rivalry?
- How big is the bargaining power of buyers?
- How significant is the bargaining power of suppliers?
- Tangible resources
- Intangible resources
- Innovation and Creativity
- Organizational capabilities
- Costly to imitate?
- Organized properly?